The SP is moving up and the buyers are gradually building upIt would be moving towards 0.030 at the end of this year IMO if everything goes according to the company business projection.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%